FOLFIRINOX：晚期胰腺癌的一种新标准治疗方案？ - Suppr

Suppr

超能文献

FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?

作者信息

Kim Richard

机构信息

H Lee Moffitt Cancer Center, Tampa, FL 33612, USA. richard.kim@moffi tt.org

出版信息

Lancet Oncol. 2011 Jan;12(1):8-9. doi: 10.1016/S1470-2045(10)70237-0. Epub 2010 Nov 1.

DOI:10.1016/S1470-2045(10)70237-0

PMID:21050812

Abstract

摘要

相似文献

FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?FOLFIRINOX：晚期胰腺癌的一种新标准治疗方案？

Lancet Oncol. 2011 Jan;12(1):8-9. doi: 10.1016/S1470-2045(10)70237-0. Epub 2010 Nov 1.

FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.

Pancreas. 2012 Aug;41(6):973-4. doi: 10.1097/MPA.0b013e3182496e90.

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.新辅助FOLFIRINOX方案治疗一系列临界可切除胰腺导管腺癌患者的安全性和有效性

Acta Oncol. 2013 Aug;52(6):1231-3. doi: 10.3109/0284186X.2013.771821. Epub 2013 Feb 27.

A R0 resection case of initially unresectable metastatic pancreatic cancer downstaged by FOLFIRINOX therapy.一例最初无法切除的转移性胰腺癌经FOLFIRINOX治疗后降期至可进行R0切除的病例。

Pancreas. 2014 Aug;43(6):972-4. doi: 10.1097/MPA.0000000000000139.

Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard?化疗：转移性胰腺癌——FOLFIRINOX方案是新标准吗？

Nat Rev Clin Oncol. 2011 Jul 5;8(8):452-3. doi: 10.1038/nrclinonc.2011.107.

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.采用FOLFIRINOX方案治疗高级别转移性胰腺神经内分泌癌。

J Gastrointest Cancer. 2015 Jun;46(2):166-9. doi: 10.1007/s12029-015-9689-0.

Three-drug combination regimen in pancreatic cancer treatment: are we there yet?胰腺癌治疗中的三联药物联合方案：我们做到了吗？

JOP. 2011 Mar 9;12(2):78-82.

Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case.一例初始局部进展期不可切除胰腺癌经FOLFIRINOX方案放化疗后达到完全放射学缓解：病例报告

Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):e29-31. doi: 10.1016/j.clinre.2014.08.011. Epub 2014 Oct 3.

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.FOLFIRINOX方案与吉西他滨治疗转移性胰腺癌的对比

N Engl J Med. 2011 Aug 25;365(8):768-9; author reply 769. doi: 10.1056/NEJMc1107627.

The role of the FOLFIRINOX regimen for advanced pancreatic cancer.FOLFIRINOX 方案在晚期胰腺癌中的作用。

Curr Oncol Rep. 2013 Apr;15(2):182-9. doi: 10.1007/s11912-012-0290-4.

引用本文的文献

Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.新辅助化疗与切除的胰腺癌中免疫细胞浸润和抗肿瘤微环境的改变相关。

Clin Cancer Res. 2022 Dec 1;28(23):5167-5179. doi: 10.1158/1078-0432.CCR-22-1125.

Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer.晚期胰腺癌患者无进展生存期与金属支架通畅性之间的关联。

J Gastrointest Oncol. 2022 Aug;13(4):1981-1988. doi: 10.21037/jgo-22-218.

5--Sinuleptolide from Soft Corals of the Genus Exerts Cytotoxic Effects on Pancreatic Cancer Cell Lines via the Inhibition of JAK2/STAT3, AKT, and ERK Activity.5-来自软珊瑚属的 Sinuleptolide 通过抑制 JAK2/STAT3、AKT 和 ERK 活性对胰腺癌细胞系发挥细胞毒性作用。

Molecules. 2021 Nov 17;26(22):6932. doi: 10.3390/molecules26226932.

An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.RNA 结合蛋白 Hu 抗原 R 在胰腺癌上皮间质转化、转移和癌症干细胞中的作用。

Mol Cancer Ther. 2020 Nov;19(11):2267-2277. doi: 10.1158/1535-7163.MCT-19-0822. Epub 2020 Sep 2.

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.多模态治疗联合 WT1 靶向树突状细胞疫苗治疗胰腺癌患者的长期生存。

Hum Vaccin Immunother. 2019;15(2):397-406. doi: 10.1080/21645515.2018.1524238. Epub 2018 Oct 12.

Neoadjuvant -paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.新辅助紫杉醇和吉西他滨用于无法接受FOLFIRINOX方案治疗的可切除边缘或局部晚期不可切除胰腺腺癌患者。

Anticancer Res. 2018 Jul;38(7):4035-4039. doi: 10.21873/anticanres.12692.

High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study.大剂量静脉内给予抗坏血酸抑制胰腺癌生长和转移：机制和 I/IIa 期研究。

Sci Rep. 2017 Dec 7;7(1):17188. doi: 10.1038/s41598-017-17568-8.

Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.靶向上皮-间质转化以鉴定胰腺癌细胞侵袭和肿瘤球形成的抑制剂

PLoS One. 2016 Oct 20;11(10):e0164811. doi: 10.1371/journal.pone.0164811. eCollection 2016.

Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.姜黄素通过减少凋亡抑制因子诱导胰腺腺癌细胞死亡。

Pancreas. 2016 Jan;45(1):101-9. doi: 10.1097/MPA.0000000000000411.

Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.胰腺腺癌患者在疾病进展时骨髓来源的抑制细胞水平会升高。

Cancer Immunol Immunother. 2015 Feb;64(2):149-59. doi: 10.1007/s00262-014-1618-8. Epub 2014 Oct 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验